MedTrace Logo

Effectiveness of Chinese Herbal Therapy for Asthma

NCT00712296 · Status: TERMINATED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 66

Last updated 2020-09-16

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine the efficacy of an anti-asthma herbal medicine intervention (ASHMI) in adult asthmatics

Conditions

Interventions

DRUG

ASHMI 4

4 capsules orally twice a day

DRUG

ASHMI 12

12 capsules orally twice a day

DRUG

Placebo

Placebo 6 capsules twice a day

Sponsors & Collaborators

Principal Investigators

  • Juan P Wisnivesky, MD, DrPH · Icahn School of Medicine at Mount Sinai

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-08-31
Primary Completion
2009-09-29
Completion
2009-09-29

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00712296 on ClinicalTrials.gov